ONCTERNAL THERAP.    O.N.
ONCTERNAL THERAP. O.N.
Share · US68236P2065 · ONCT · A40063 (XNCM)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - -0,34 % -93,01 % -98,94 %

Company Profile for ONCTERNAL THERAP. O.N. Share

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.

Company Data

Name ONCTERNAL THERAP. O.N.
Company Oncternal Therapeutics, Inc.
Symbol ONCT
Website https://www.oncternal.com
Primary Exchange XNCM Frankfurt
WKN A40063
ISIN US68236P2065
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. James B. Breitmeyer M.D., Ph.D.
Country United States of America
Currency EUR
Employees 0,0 T
Address 12230 El Camino Real, 92130 San Diego
IPO Date 2004-02-03

ID Changes

Date From To
10.06.2019 GTXI ONCT

Ticker Symbols

Name Symbol
NASDAQ ONCT

More Shares

Investors who ONCTERNAL THERAP. O.N. hold also have the following shares in their portfolio:
INTER-AMERICAN DEVELOPMENT BANK ZERO CPN CALL NTS 17/08/40
INTER-AMERICAN DEVELOPMENT BANK ZERO CPN CALL NTS 17/08/40 Bond
LB.HESS.-THR. H328 19/27
LB.HESS.-THR. H328 19/27 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025